IOWH-032

DB12959InvestigationalSmall molecule

Iowh032 has been investigated for the treatment of Cholera, Diarrhea, and Secretory Diarrhea.

Mechanism: Pharmacologically active on Cystic fibrosis transmembrane conductance regulator
Curator reviewed
Formula / weight: C₂₂H₁₅Br₂N₃O₄ · 545.187 g/mol (avg)
Code names: IOWH-032

Resolves to

Compound

Structure

InChIKeyDSFNLJXHXBIKDS-UHFFFAOYSA-NSMILESOC1=C(Br)C=C(C=C1Br)C1=NOC(=N1)C(=O)NCC1=CC=C(OC2=CC=CC=C2)C=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with IOWH-032, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.